Pharmacology Discovery Services

Pharmacology Discovery Services (PDS) is your best in vivo partner to establish pre-clinical proof-of-concept. Bringing over 50 years of experience to drug discovery, PDS specializes in non-GLP efficacy and PK studies, tailored to meet the in vivo pharmacology needs of our clients. As a premier CRO and a trusted partner lab of Eurofins Discovery, we offer a comprehensive selection of 350+ validated efficacy models in six major therapeutic areas including antimicrobial, inflammation, oncology, metabolic, gastrointestinal/renal, and CNS/pain, incorporating biomarkers and outcome measures to enable greater prediction of success in the clinic. We deliver flexible and collaborative custom programs designed to...

Drug discovery,in vivo pharmacology,antimicrobial models,inflammation models,oncology models,metabolic models,gastrointestinal/renal models,cns/pain models,biomarkers,and pre-clinical

Pharmacology discovery services operates in the Biotechnology research industry.

Pharmacology discovery services's revenue is 11m - 100m

Pharmacology discovery services has 11 - 50 employees.